Amgen Balance Sheet
NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Amgen financial position
At the end of fiscal 2025, Amgen reported total assets of $90.59 billion, down 1.4% from a year earlier against total liabilities of $81.93 billion. Shareholders' equity stood at $8.66 billion, or 9.6% of assets. The company held $9.13 billion in cash and equivalents against $54.60 billion of debt, a net debt position of $45.48 billion.
The current ratio (current assets divided by current liabilities) was 1.14, meaning short-term assets cover obligations due within a year. Debt-to-equity was 6.31.
Summary generated from market data by MetaCap's automated system. Methodology
Amgen balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.13B | 11.97B | 10.94B | 7.63B | 7.99B | 6.27B | 6.04B | 6.95B | 3.80B | 3.24B |
| Short-Term Investments | — | — | 0 | 1.68B | 48.00M | 4.38B | 2.87B | 22.36B | 37.88B | 34.84B |
| Receivables | 9.57B | 6.78B | 7.27B | 5.56B | 4.89B | 4.53B | 4.06B | 3.58B | 3.24B | 3.17B |
| Inventory | 6.22B | 7.00B | 9.52B | 4.93B | 4.09B | 3.89B | 3.58B | 2.94B | 2.83B | 2.75B |
| Total Current Assets | 29.06B | 29.03B | 30.33B | 22.19B | 19.39B | 21.14B | 18.44B | 37.62B | 49.48B | 46.01B |
| Property, Plant & Equipment | 7.91B | 6.54B | 5.94B | 5.43B | 5.18B | 4.89B | 4.93B | 4.96B | 4.99B | 4.96B |
| Goodwill | 18.68B | 18.64B | 18.63B | 15.53B | 14.89B | 14.69B | 14.70B | 14.70B | 14.76B | 14.76B |
| Intangible Assets | 22.28B | 27.70B | 32.64B | 16.08B | 15.18B | 16.59B | 19.41B | 7.44B | 8.61B | 10.28B |
| Total Assets | 90.59B | 91.84B | 97.15B | 65.12B | 61.16B | 62.95B | 59.71B | 66.42B | 79.95B | 77.63B |
| Accounts Payable | 2.37B | 1.91B | 1.59B | 1.57B | 1.37B | 1.42B | 1.37B | 1.21B | 1.35B | 917.00M |
| Short-Term Debt | 4.60B | 3.55B | 1.44B | 1.59B | 87.00M | 91.00M | 2.95B | 4.42B | 1.15B | 4.40B |
| Total Current Liabilities | 25.49B | 23.10B | 18.39B | 15.69B | 12.18B | 11.65B | 12.84B | 13.49B | 9.02B | 11.20B |
| Long-Term Debt | 50.01B | 56.55B | 63.17B | 37.35B | 33.22B | 32.90B | 26.95B | 29.51B | 34.19B | 30.19B |
| Total Liabilities | 81.93B | 85.96B | 90.92B | 61.46B | 54.47B | 53.54B | 50.03B | 53.92B | 54.71B | 47.75B |
| Shareholders' Equity | 8.66B | 5.88B | 6.23B | 3.66B | 6.70B | 9.41B | 9.67B | 12.50B | 25.24B | 29.88B |
| Retained Earnings | -25.11B | -27.59B | -26.55B | -28.62B | -24.60B | -21.41B | -21.33B | -17.98B | -5.07B | -438.00M |
| Total Debt | 54.60B | 60.10B | 64.61B | 38.95B | 33.31B | 32.99B | 29.90B | 33.93B | 35.34B | 34.60B |
| Net Cash (Debt) | -45.48B | -48.13B | -53.67B | -29.64B | -25.27B | -22.34B | -20.99B | -4.63B | 6.34B | 3.49B |
| Shares Outstanding | 538.80M | 536.90M | 535.40M | 534.00M | 558.30M | 578.30M | 591.40M | 629.60M | 722.20M | 738.20M |
This table shows 10 annual periods of Amgen's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow AMGN's reporting calendar. What is a balance sheet?